Wells Fargo’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-70,000
Closed -$6.02M 7483
2022
Q1
$6.02M Sell
70,000
-21,500
-23% -$1.77M ﹤0.01% 2287
2021
Q4
$7.47M Hold
91,500
﹤0.01% 2135
2021
Q3
$6.08M Hold
91,500
﹤0.01% 2654
2021
Q2
$6.13M Hold
91,500
﹤0.01% 2671
2021
Q1
$4.76M Hold
91,500
﹤0.01% 2909
2020
Q4
$275K Buy
+91,500
New +$2.95M ﹤0.01% 4914
2018
Q1
Sell
-1,073,500
Closed -$825K 6567
2017
Q4
$825K Hold
1,073,500
﹤0.01% 4053
2017
Q3
$1.74M Buy
1,073,500
+998,400
+1,329% +$16.9M ﹤0.01% 3417
2017
Q2
$86K Hold
75,100
﹤0.01% 5225
2017
Q1
$153K Buy
75,100
+49,800
+197% +$924K ﹤0.01% 4973
2016
Q4
$409K Sell
25,300
-4,200
-14% -$75.3K ﹤0.01% 4334
2016
Q3
$253K Buy
+29,500
New +$768K ﹤0.01% 4342

Other funds holding THC

Wells Fargo's THC Position: Q1 2026 in Review

Wells Fargo reduced its Tenet Healthcare (THC) stake by 2.7% in Q1 2026, selling an estimated $1.44M and leaving 249,633 shares worth $47.1M. The position accounts for 0.01% of the portfolio, ranked #1003.

Wells Fargo first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $51M in Q4 2025. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Wells Fargo held 249,633 shares of Tenet Healthcare worth $47.1M as of Q1 2026.
  • Wells Fargo sold 6,851 Tenet Healthcare shares in Q1 2026, an estimated $1.44M.
  • Tenet Healthcare made up 0.01% of Wells Fargo's portfolio in Q1 2026, its #1003 holding.
  • Wells Fargo first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Tenet Healthcare position peaked at $51M in Q4 2025.
  • 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.